Navigation Links
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results

ensation from fiscal 2008 equity grants and a mark-to-market adjustment on Stock Appreciation Rights.

During the six-month period, the Company generated cash from operations of $13.6 million and reported $71.3 million of cash and interest bearing investment balances and total debt of $33.5 million at December 31, 2008.

The following chart presents a summary reconciliation of the Company's earnings per share for the six months ended December 31, 2008, and the Company's adjusted earnings per share for the comparable period of the prior fiscal year. See attached schedules for a detailed reconciliation between the non-GAAP and reported GAAP results.

                                                  Six Months         Year
                                              Ended December 31,  over Year %
    ($millions, except per share data)        2008        2007      Change
    Data as Reported:
    Pre-tax Income, As Reported              $15.3        $3.4       345%
    Adjust for:
         Discontinuation of Embolic
          Protection                             -        $0.3        n/m
         Acceleration of Stock Awards            -        $3.0        n/m
    Pre-tax Income, As Adjusted              $15.3        $6.8       127%
    Earnings Per Share, As
     Reported/Adjusted                       $0.87       $0.36       142%
      Supplemental Information related to
       Equity Compensation Expense:
    Equity Compensation Expense (Six Months
     ended December 31, 2007 prior to
     acceleration)                            $0.3        $1.5      (78%)
    Equity Compensation Related to
     Acceleration of Stock Awards                -        $3.0        n/m
    Total Equity Compensation Expense         $0.3        $4.4      (93%)
    Equity Compensation Expense Per Share
     (net of tax)                            $0.02       $0.23      (91%)


SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
9. GEN Reports on Growing Reliance on Microfluidics Technology
10. Novozymes Reports Strong 2008 Results
11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
Post Your Comments:
(Date:8/21/2014)... , Aug. 21, 2014 OTC ... Pharmaceuticals Inc., a biotechnology company, on its approval ... previously traded on OTCQX®, the best marketplace for ... Markets Group. Logo - ... the successful execution of its growth strategy and ...
(Date:8/21/2014)... 2014 Pursuit Solutions ( ... and services for Life Sciences sales and marketing ... of New Commercial Sales Models” by Peter Robinson, ... The article examines some innovative models used to ... tested in the pharmaceutical market. Robinson grades the ...
(Date:8/21/2014)... Boston, MA (PRWEB) August 21, 2014 ... collaboration company, has been recognized as one of ... 500 | 5000 magazine for the 2nd consecutive ... on its 33rd annual Inc. 500|5000, an exclusive ... list represents the most comprehensive look at the ...
(Date:8/20/2014)... patented university inventions licensed to biotechnology firms has ... To open these roadblocks, the researchers suggest that ... discovery stage could lead to faster commercialization down ... from discoveries made in university laboratories and licensed ... clinical trials, which have a high failure rate. ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... Argenta Advisors(TM), a leading,national life science reimbursement ... joined the team as a medical director for ... leadership of Chief Medical Officer Dr. Brent,O,Connell, guides ... review and payer coverage. Argenta TEC facilitates the,coverage ...
... Its Kind Instant Dissolve Powder Antacid Delivers Faster Relief, ... Increased Convenience and Great Taste, ... a $20 million integrated marketing campaign,for the new TUMS(R) QuikPak(TM), ... TUMS brand. The QuikPak campaign, part of,a larger new "Bring ...
... NVAX ) a clinical-stage vaccine company, announced today that ... presenting at,the World Vaccine Congress 2008 at 11:25 a.m. ... provide an overview of the company,s,strategy, research and development ... Finalist for the Vaccine Industry,Excellence (VIE) Awards 2008 in ...
Cached Biology Technology:Dr. Elizabeth Brown Joins Argenta TEC 2New TUMS(R) QuikPak(TM) Campaign Offers Innovative Heartburn Relief with a Little Help from the Jetsons 2
(Date:8/21/2014)... A study recently published in the journal ... shows a new role for the protein adenomatous polyposis ... cause of cancer-related deaths in the U.S. , Lead ... Molecular Biosciences and co-leader of the Cancer Biology program ... part of her career trying to understand the various ...
(Date:8/21/2014)... An Australian National University (ANU) team has successfully replicated ... way for biological systems powered by sunlight which could ... and so is sunlight. It is an exciting prospect ... cheaply and safely," said Dr Kastoori Hingorani, from the ... ANU Research School of Biology. , Hydrogen offers potential ...
(Date:8/20/2014)... 2014 George E. Fox, a John and Rebecca Moores ... (UH), was named a fellow in the International Society for ... Fox is one of four members two from the ... as fellows in 2014. Fellows are elected every three years, ... 500 members from more than 20 countries, the ISSOL includes ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Water and sunlight the formula for sustainable fuel 2UH professor named fellow by International Astrobiology Society 2
... at the University of Leicester have released satellite images of ... which are currently sweeping across central and western Russia. ... University,s Earth Observation Science group have analysed and released still ... satellite image is available as both a true colour image ...
... soap can help build electrodes for cheaper lithium ion ... of Nano Letters . The one-step method will ... lithium ion-metal oxide batteries currently on the market. ... electrode materials," said material scientist Daiwon Choi of the ...
... Montreal, August 12, 2010 Dr. Jean-Philippe ... unit at the Institut de recherches cliniques de ... for modulating vascular permeability: the nitrosylation of beta-catenin ... have a possible impact on the treatment of ...
Cached Biology News:Fires around Moscow: A satellite perspective 2Wax, soap clean up obstacles to better batteries 2Wax, soap clean up obstacles to better batteries 3Wax, soap clean up obstacles to better batteries 4An IRCM researcher pinpoints the cellular mechanism responsible for modulating the permeability of blood vessels 2
Ready-to-use solution....
Applications: ISH...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
Biology Products: